REGISTER FOR THE APRIL 2010 EVENT TODAY!
Organised by LSP (Life Sciences Partners) and MeesPierson Corporate Finance & Capital Markets companies, BioCapital Europe is now in its 8th successful consecutive year and has established itself as a platform allowing the most promising and emerging biotech companies from the Benelux as well as a selection of quality biotech companies from other European countries to present to an audience of dedicated biotech VCs and institutional investors.
BioCapital Europe has become a showcase for the industry's progress in these regions, attracting up to 200 high quality delegates (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors).
The conference will be held on Thursday 29th April 2010. VCs and Institutional Investors are invited to attend free of charge to this event.
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing to private and public life-science companies. Since the late 1980s, LSP's management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. For example, LSP was a founding investor in Crucell, DNage, Qiagen, Rhein Biotech and Pharming. With over EUR 500 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe's largest and most experienced specialist life-science investors. For more information about the LSP Group, please visit the website www.lspvc.com.
|
The dedicated healthcare team of MeesPierson Corporate Finance & Capital Markets, based in Amsterdam and Frankfurt, has an established track record of successfully completed equity capital markets and M&A transactions. Its pan-European healthcare corporate finance franchise is focused on a wide variety of segments, including biotechnology, (specialty) pharma, life sciences, medical equipment and devices, and healthcare services. As one of the oldest European merchant banks, we value the tradition of building long-term, personalized relationships with our clients.
MeesPierson Corporate Finance & Capital Markets is part of Fortis Bank Nederland, which is a financial services provider that offers a broad range of products and services to individuals, businesses and institutions in the Netherlands and abroad. Our main activities are retail banking, private banking, commercial banking and merchant banking. Most of our financial services are provided under the Fortis Bank Nederland brand, while our private banking and corporate finance operations are conducted under the MeesPierson label. We have activities in 25 countries across the globe and are the fourth biggest bank in the Netherlands. Fortis Bank Nederland is moving ahead towards creating a new, strong Dutch bank together with ABN AMRO. For more information please visit www.merchant-banking.nl or www.meespierson-cfcm.nl
Click here to register for the event
